Related Experiment Video
Updated: Jun 15, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Medicine-related questions handled by community pharmacists: an exploratory study
Paul M Rutter1, Sharon Warren, Jill Rutter
1Department of Pharmacy, School of Applied Sciences, University of Wolverhampton, Wolverhampton, UK. paul.rutter@wlv.ac.uk
Objectives:
The objectives of this study were to determine what type of medicine-related questions community pharmacists were asked and to ascertain whether responses given were appropriate.
Methods:
All community pharmacists from three Primary Care Trusts were invited to participate in a week-long exploratory study. Piloted data-collection forms were self-completed. Data were analysed descriptively using Microsoft Excel and statistical tests conducted with Minitab.
Key Findings:
Sixty-six medicines-related questions were answered by participating pharmacists. The type of questions asked were varied and asked by patients, the general public and health care professionals. Most answers (over 80%) were assessed as being appropriate; only four questions raised concern with assessors that possible patient harm may have resulted. Almost half (42%) of the questions were answered without consultation to any reference source.
Conclusions:
Despite the small-scale nature of the study the findings show that community pharmacists provide a good-quality service that is easily accessible to all people. However, the failure to use reference sources may impact on pharmacists' ability to answer medicine-related questions fully.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Analysis of Population Pharmacokinetic Data
Bioavailability Study Design: Healthy Subjects Versus Patients
Dosage Regimens: Partial Pharmacokinetic Parameters
Pharmacogenetics and Pharmacogenomics: Overview